Patents

iMDsoft Announces that United States Patent Office Re-Examination Successfully Limits Visicu Patent

Published in Medical Patent Law Weekly, March 14th, 2007

The second re-examination requested by iMDsoft of a healthcare services patent owned by Visicu, Inc. has resulted in Visicu limiting all its patent claims.

On February 6, 2007, the United States Patent and Trademark Office (USPTO) held all claims in Visicu's patent No. 6,804,656 to be invalid as not patentable.

The invalidity finding was based on prior art that includes iMDsoft's own patent disclosure, which pre-dates Visicu's patent.

All of the claims in Visicu's patent are affected.

The invalidity rejection by the USPTO forced Visicu on February 15, 2007 to narrow all the patent claims to require that the...

Want to see the full article?

Purchase this article for only $3.00

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Medical Patent Law Weekly

Source: Medical Patent Law Weekly (2007-03-14)

NewsRx is Social

Top Medical Newsletters

Awards

Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

Google 2010 PageRank: #2 Among Top Health News and Media Publications
Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry